According to the news report, the device giant is ready to commit to an acquisition priced at “$10 million to something much more significant” in order to expand its offerings in minimally invasive surgery. The company has $221 million in cash and equivalents as of June 30.
More Articles on Orthopedic Devices:
RTI Biologics Reports $45.2M 2Q Revenue, Up 4%
ArthroCare 2Q Revenue Hits $91.7M, Up 0.5%
Globus Medical Announces Pricing of Initial Public Offering
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
